0(0%) Volume: 1,087,007 3:15AM EST| Market Cap : 14.17 B | Enterprise Value : 14.31 B | P/E (TTM) : | P/B : 4.61 |
|---|
NAS:BMRN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:BMRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Biomarin Pharmaceutical's Cost of Goods Sold for the three months ended in Sep. 2019 was $97 Mil. Its Revenue for the three months ended in Sep. 2019 was $461 Mil.
Biomarin Pharmaceutical's COGS to Revenue for the three months ended in Sep. 2019 was 0.21.
Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Biomarin Pharmaceutical's Gross Margin % for the three months ended in Sep. 2019 was 78.97%.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
| Biomarin Pharmaceutical Quarterly Data | ||||||||||||||||||||
| Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | |
| COGS-to-Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.20 | 0.21 | 0.22 | 0.20 | 0.21 |
Biomarin Pharmaceutical's COGS to Revenue for the fiscal year that ended in Dec. 2018 is calculated as
| COGS to Revenue | = | Cost of Goods Sold | / | Revenue |
| = | 315.264 | / | 1491.212 | |
| = | 0.21 |
Biomarin Pharmaceutical's COGS to Revenue for the quarter that ended in Sep. 2019 is calculated as
| COGS to Revenue | = | Cost of Goods Sold | / | Revenue |
| = | 96.949 | / | 461.097 | |
| = | 0.21 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.
Biomarin Pharmaceutical's Gross Margin % for the three months ended in Sep. 2019 is calculated as:
| Gross Margin % | = | 1 | - | COGS to Revenue |
| = | 1 | - | Cost of Goods Sold / Revenue | |
| = | 1 | - | 96.949 / 461.097 | |
| = | 78.97 % |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.
No Headline
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP